4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Zonisamide: new trials by email Literature Review of Zonisamide trials Research Report on Zonisamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Noise-Induced Hearing Loss-Acute Exposure Treatment (UA) Zonisamide 100Mg Cap, Placebo - Hearing Loss, Noise-Induced | Phase 2 | Terminated | Washington University School of Medicine | 3 | 2021-11-10 | 2026-02-13 |
| Noise-Induced Hearing Loss-Acute Exposure Treatment Zonisamide 100Mg Cap, Placebo - Hearing Loss, Noise-Induced | Phase 2 | Terminated | Washington University School of Medicine | 24 | 2021-10-04 | 2025-01-15 |
| Zonisamide for Heavy Drinkers With Bipolar Disorder Zonisamide, Placebo - Alcohol Use Disorders, Bipolar Disorder | Phase 2 | Terminated | Yale University | 3 | 2012-05-01 | 2017-01-13 |
| Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism Topiramate, Zonisamide, Levetiracetam - Alcoholism, Alcohol Dependence | Phase 2 | Terminated | Boston Medical Center | 85 | 2009-05-01 | 2015-04-28 |
Alcoholism (2) · Hearing Loss, Noise-Induced (2) · Alcoholic Intoxication (1) · Bipolar Disorder (1) · Substance-Related Disorders (1)
Washington University School of Medicine (2) · Boston Medical Center (1) · Yale University (1)
United States (4)
Craig A Buchman, MD, FACS (2) · Albert J Arias, MD (1) · Domenic A Ciraulo, MD (1)
K23AA017689 (1), P60AA013759 (1), R01AA015923 (1)